Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,179 | 24 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $295.09 | 8 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $168.27 | 3 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $163.89 | 3 | $0 (2020) |
| Amgen Inc. | $126.84 | 3 | $0 (2019) |
| Gilead Sciences, Inc. | $117.70 | 1 | $0 (2020) |
| La Jolla Pharmaceutical Company | $116.40 | 1 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $95.03 | 2 | $0 (2018) |
| Allergan, Inc. | $64.46 | 1 | $0 (2019) |
| Jazz Pharmaceuticals Inc. | $17.19 | 1 | $0 (2020) |
| Novo Nordisk Inc | $14.11 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $19.11 | 1 | AstraZeneca Pharmaceuticals LP ($19.11) |
| 2021 | $116.40 | 1 | La Jolla Pharmaceutical Company ($116.40) |
| 2020 | $280.41 | 5 | Boehringer Ingelheim Pharmaceuticals, Inc. ($119.16) |
| 2019 | $617.48 | 11 | PFIZER INC. ($245.68) |
| 2018 | $145.58 | 6 | Merck Sharp & Dohme Corporation ($95.03) |
All Payment Transactions
24 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/12/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: Respiratory | ||||||
| 05/20/2021 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $116.40 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 03/12/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $119.16 | General |
| Category: DIABETES | ||||||
| 02/20/2020 | Gilead Sciences, Inc. | Biktarvy (Drug) | Food and Beverage | In-kind items and services | $117.70 | General |
| Category: HIV | ||||||
| 02/13/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS, Tresiba | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: Diabetes | ||||||
| 02/10/2020 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $12.25 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/24/2020 | Jazz Pharmaceuticals Inc. | SUNOSI (Drug) | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: NEUROLOGY | ||||||
| 12/16/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/13/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $110.41 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/02/2019 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $108.53 | General |
| Category: Bone Health | ||||||
| 09/26/2019 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $117.20 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/10/2019 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/29/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $12.29 | General |
| Category: RESPIRATORY | ||||||
| 05/30/2019 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $4.92 | General |
| Category: Neuroscience | ||||||
| 04/23/2019 | Allergan, Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $64.46 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/11/2019 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $24.16 | General |
| 03/04/2019 | PFIZER INC. | TALZENNA (Drug) | Food and Beverage | In-kind items and services | $4.97 | General |
| Category: ONCOLOGY | ||||||
| 01/11/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $32.44 | General |
| 12/12/2018 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/05/2018 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $12.21 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/30/2018 | Merck Sharp & Dohme Corporation | PNEUMOVAX 23 (Biological) | Food and Beverage | In-kind items and services | $11.41 | General |
| Category: VACCINE | ||||||
| 10/22/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $10.88 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 05/10/2018 | Merck Sharp & Dohme Corporation | ZEPATIER (Drug) | Food and Beverage | In-kind items and services | $83.62 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 04/18/2018 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: Endocrinology | ||||||
About Dr. Katherine Dittman, DO
Dr. Katherine Dittman, DO is a Critical Care Medicine healthcare provider based in Fairfield, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/14/2017. The National Provider Identifier (NPI) number assigned to this provider is 1316486129.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Katherine Dittman, DO has received a total of $1,179 in payments from pharmaceutical and medical device companies, with $19.11 received in 2024. These payments were reported across 24 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($1,179).
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Pulmonary Disease
- Location Fairfield, CA
- Active Since 02/14/2017
- Last Updated 02/05/2025
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1316486129
Products in Payments
- ELIQUIS (Drug) $162.04
- LOKELMA (Drug) $125.00
- JARDIANCE (Drug) $119.16
- Biktarvy (Drug) $117.70
- VYNDAQEL (Drug) $117.20
- GIAPREZA (Drug) $116.40
- EVENITY (Biological) $108.53
- ZEPATIER (Drug) $83.62
- DALVANCE (Drug) $64.46
- FASENRA (Biological) $19.11
- SUNOSI (Drug) $17.19
- Ozempic (Drug) $14.11
- Prolia (Biological) $13.39
- STIOLTO RESPIMAT (Drug) $12.29
- PNEUMOVAX 23 (Biological) $11.41
- CHANTIX (Drug) $10.88
- TALZENNA (Drug) $4.97
- Aimovig (Biological) $4.92
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Fairfield
Ankur Girdhar, M.d, M.D
Critical Care Medicine — Payments: $11,524
Zohaib Akhtar, M.d, M.D
Critical Care Medicine — Payments: $6,280
Sanjiv Patel, Md, MD
Critical Care Medicine — Payments: $1,809
Gifty John
Critical Care Medicine — Payments: $265.46
Mrs. Hasmin Nales, Rn, RN
Critical Care Medicine
Sanjani Mendoza
Critical Care Medicine